Haven't used selectION yet?
Ask Trustburn

Ask Trustburn about selectION

Based on 8 reviews on Trustburn

Based on reviews on this page. Verify anything important with the company directly.

Bob Hicks
Reviews 1

I have been a customer of selectION for a while now and I must say that I am extremely satisfied with their services. Their website is user-friendly and their customer support team is always responsive. I would rate my experience with selectION as excellent.

William Webster
Reviews 1

My experience with selectION has been quite positive. The company's website is easy to navigate and the services provided are top-notch. I am very satisfied with their professionalism and attention to detail. Overall, I would rate selectION as great.

Brianna
Reviews 1

selectION is a decent company. I have used their services for a few months now and I am quite satisfied with the results. The website is easy to navigate and the customer service is responsive. Overall, I would rate my experience with selectION as average.

Diane Dicicco
Reviews 1

My recent experience with selectION has been fantastic! 🌟 Their website is top-notch and their customer service is always there to help. I am highly impressed with their professionalism and attention to detail. Keep up the great work!

Questions & Answers

No questions yet — be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="selectiontherapeutics-com" data-lang="en"></div>
More widgets

About selectION

selectION has established an efficient technology platform to develop highly selective peptide blockers for ion channels. Their most advanced drug candidate is si-544 which is a best-in-class Kv1.3 blocker for treatment of effector memory T cell (TEM) driven diseases.

The company is well positioned to expand its range of class-leading ion channel blockers by targeting additional potassium, sodium, calcium and chloride channels, which will lead to other clinical applications in pain management and oncology.